TScan Therapeutics
TCRX
TCRX
28 hedge funds and large institutions have $69.9M invested in TScan Therapeutics in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 5 closing their positions.
Holders
28
Holders Change
–
Holders Change %
0%
% of All Funds
0.44%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
5
Increased
8
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
1
BlackRock
New York
|
$3.16M |
| 2 |
NM
2
Newtyn Management
New York
|
$0 |
| 3 |
BCM
3
Bridgeway Capital Management
Houston,
Texas
|
$125K |
| 4 |
4
Morgan Stanley
New York
|
$271K |
| 5 |
CC
5
Cannell Capital
Alta,
Wyoming
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
ACA
26
Atlas Capital Advisors
Jackson,
Wyoming
| $2.24K | 896 | – | – |
|
27
Bank of America
Charlotte,
North Carolina
| $500 | 200 | – | – |
|
28
Wells Fargo
San Francisco,
California
| $200 | 80 | +5 | +7% |
|
|
NM
29
Newtyn Management
New York
| – | – | -236,800 | Closed |
|
|
CC
30
Cannell Capital
Alta,
Wyoming
| – | – | -14,666 | Closed |
|
31
LPL Financial
San Diego,
California
| – | – | -12,000 | Closed |
|
|
TRCT
32
Tower Research Capital (TRC)
New York
| – | – | -4,147 | Closed |
|
33
Osaic Holdings
Scottsdale,
Arizona
| – | – | -1 | Closed |
|
|
CFGS
34
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|